NIH student loan repayment program for up to $35,000 annually

The NIH is accepting applications for its annual Extramural Loan Repayment Program. If you’re a health professional pursuing a career in biomedical, behavioral, social or clinical research, and plan to commit at least two years to research, you may be eligible for up to $35,000 per year. The program is divided into five subdivisions:

Applications accepted from Sept. 1 through Nov. 16, 2015, 8 p.m. EST.

Eligibility requirements for each program can vary, so be sure to read the full notices. For all Loan Repayment Programs, applicants must be U.S. citizens, nationals, or permanent residents and have a doctoral degree from an accredited institution. Applicants must engage in research that averages at least 20 hours a week during each quarterly service period per contract quarter. Total qualifying educational debt must be equal to or exceeding 20 percent of applicants institutional base salary at the time of award.

Note that these grants are awarded to the individual and do not go through OHSU’s system. However, you must work with OHSU’s pre-award office to verify your affiliation with the university.

Annual Oregon Bioscience conference coming in September; submit abstracts by Aug. 14

Oregon Bioscience conferenceThe Oregon Bioscience Association‘s 2015 annual conference is just around the corner, and poster abstracts submissions are being accepted through Friday, Aug. 14.

The poster session is a great opportunity for academic researchers and start-up companies to share their research innovations and obtain valuable feedback from local industry leaders, biotech executives, investors, and other conference attendees. The poster session and other conference events also provide a valuable forum for networking, establishing new collaborations and partnerships, and for learning about exciting developments within the Northwest bioscience community.

The abstract submission deadline is Friday, Aug. 14.

Who should submit a poster abstract?
Abstracts for Posters from both academic researchers and bioscience companies in Oregon are encouraged. Students and postdocs who present posters at the conference will be granted free registration to Conference Day One. All posters will be eligible for outstanding poster awards within their respective category.

Please submit your abstract by Friday, Aug. 14. Poster space is limited. You will be notified if your poster was accepted for presentation.

About the conference
The Oregon Bioscience Association 2015 annual conference: Expanding the ecosystem
Wednesday and Thursday, Sept. 9 and 10, 2015

Conference Day One held at the Collaborative Life Sciences Building, 2730 S.W. Moody Ave., in Portland
Conference Day Two held at Marylhurst University, 17600 Pacific Highway (Hwy. 43), south of Portland

Get the conference schedule here.
Register now.

Questions? Please contact Mike Matrone at or Sarah Biber at


Brendan Rauw named vice president of technology transfer and business development

Brendan Rauw photo_for RNBrendan Rauw, MBA, has joined OHSU as vice president, technology transfer and business development, a division of OHSU’s research mission that supports technology commercialization, industry collaboration, and entrepreneurship.

Rauw comes to OHSU from UCLA, where he served as associate vice chancellor and executive director of entrepreneurship. In this role at UCLA, he was responsible for leading a variety of programs designed to advance innovation, entrepreneurship, and the transfer of intellectual property into real-world applications. He also guided the establishment of a separate, nonprofit 501(c)(3) corporation – Westwood Technology Transfer – to oversee technology transfer and industry-sponsored research, and served as the founding CEO.

Rauw’s move to OHSU was a natural one. “It is an exciting time to be at OHSU. The Knight Cancer Challenge just shows that world-class research is going on here. I see a lot of opportunity that TTBD can help move forward for the benefit of patients and society.”

The city itself was also a factor in taking the job. “There’s a strong entrepreneurial spirit in Portland. It’s a unique place for collaboration and expansion of ideas. Leading venture firms are becoming interested in the startups being generated in Portland today.”

Rauw added, “The success of TTBD and the greater Portland life science community are closely linked.”

That’s particularly helpful as he steps into this role, given he is responsible for forging a successful, dynamic program to advance OHSU’s goal of substantially increasing the commercialization of its intellectual property and increasing industry research collaborations.

Rauw is no stranger to taking risks. He has been a founder in four startup companies, and prior to UCLA, he helped establish the office of technology transfer and innovation at the King Abdullah University of Science and Technology in Saudi Arabia, a private university with a $20 billion endowment. He was also a director on the senior leadership team of Columbia Technology Ventures in New York, responsible for Columbia University’s intellectual property investment and management.

Rauw came to university technology transfer after a career in strategy consulting and business development. He was a management consultant in the New York office of the Boston Consulting Group, where he advised major private equity and biopharmaceutical companies on topics such as corporate acquisitions, innovation strategy and R&D design, including two $40+ billion acquisitions. He also worked in corporate development with Genzyme Corporation.

He believes his diverse global experience will help OHSU advance the commercialization of the intellectual property being generated.

“I think the role of technology transfer and business development is to advance commercialization of research for the benefit of patients and society. If we do our job well, the dollars will follow.” He added, “In the end, our success rests on our relationships with faculty. They need to know what we offer and how we can help them, and we need to deliver on that promise.”

Rauw holds an undergraduate degree in biology from Harvard College and an MBA from Harvard Business School. A native of Calgary, Canada, he has a wide range of interests and hobbies. He is an advanced SCUBA diver, with more than 20 years of experience diving all over the world. He is also a martial artist who became an instructor in high school. Since then, he has studied Shaolin kung fu in China, and Muay Thai kickboxing in Thailand. While working at UCLA, Rauw also completed culinary school at the New School of Cooking.

Rauw has big aspirations for TTBD and OHSU. “There are established biotech clusters in San Francisco, Seattle, and Boston. I hope to help OHSU play a critical role in Portland becoming an emerging cluster.”

Save the date: 2015 TTBD awards, Oct. 19

The Technology Transfer & Business Development (TTBD) awards ceremony is an annual celebration that recognizes OHSU community members for their efforts in licensing, sponsored research, patenting, and entrepreneurship. Mark your calendars for the 2015 TTBD awards ceremony.

Save the date!
Daniel Dorsa & Arthur VandenbarkMonday, Oct. 19
5 to 8 p.m.
Collaborative Life Sciences Building

This event will include:

  • Awards and recognition for OHSU innovation and entrepreneurship
  • Reception with complimentary refreshments
  • Remarks from:
    • Daniel Dorsa, senior vice president for research
    • Jeanette Mladenovic, executive vice president and provost
    • Brendan Rauw, vice president of technology transfer and business development
    • Andrew Watson, director of technology transfer

More information and registration will be coming soon. For questions regarding this event, please contact Karen Boren at

NIH seeks input on 5-year strategic plan

The National Institutes of Health is inviting comments and suggestions on a framework for the NIH-wide Strategic Plan. In response to a request from Congress, NIH is developing a comprehensive 5-year Strategic Plan with input from senior leadership and staff from all 27 Institutes, Centers, and Offices (ICOs). NIH is also calling for contributions from the research community on the proposed framework that identifies priority areas of research and a set of principles to guide the NIH over the coming years.

The Request for Information identifies three priority cross-cutting Areas of Opportunity:
promote fundamental science, improve health promotion and disease prevention, and advance treatments and cures. Related to these areas, information requested includes but is not limited to:

  • Potential benefits, drawbacks/challenges, and areas of consideration for the current framework
  • Compatibility of the framework with the broad scope of the NIH mission
  • Additional concepts in ICO strategic plans that are cross-cutting and should be included in this trans-NIH strategic plan
  • Comprehensive trans-NIH research themes that have not been captured in the Areas of Opportunity that Apply Across Biomedicine
  • Components of the cross-cutting Areas of Opportunity that are not applicable to an NIH-wide Strategic Plan
  • Future opportunities or emerging research needs

This is a time-sensitive request – all comments must be submitted electronically on the submission website by August 16. Read the full RFI for further submission guidelines.


Who’s new at OHSU? Maros Ferencik, M.D., Ph.D.

Maros Ferencik, M.D., Ph.D., is a clinical scientist whose research focus is cardiac imaging. He joined the faculty at OHSU in January 2014.

Where are you from originally?
Slovakia. I went through medical school and earned my Ph.D. there.

Where were you before coming to OHSU?
I did my initial medical training in Slovakia for three and half years. During that time, I also spent a year on a research fellowship at the University of Massachusetts. I returned to the U.S. after my training and spent twelve years at Massachusetts General Hospital in Boston in the Harvard system. I did almost five years of research and my internal residency and cardiology training there.

Crater Lake, Oregon

Crater Lake, Oregon

What brought you to OHSU?
I was looking for new growth opportunities, mostly on the research front, and when I interviewed with Sanjiv Kaul, I realized there was a lot of support here for growing the cardiovascular research program within the Knight Cardiovascular Institute. In addition, my wife is a hematologist oncologist, and she was offered a position here, so that also factored into our decision.

How do you balance your clinical practice with your research?
My goal is to spend three-fourths of my time on research, though that’s not always possible. But my research is clinical research, so it melds together with some of my clinical imaging duties. My research focus is in imaging, primarily cardiac computed tomography (CT) imaging, which I also do as part of my clinical work.

What specific applications of cardiac CT imaging are you exploring?
I would summarize my research focus as exploring the use of cardiac CT for more efficient use in clinical practice to improve our ability to both detect disease and predict future events. As such, I have a few areas of interest. I work closely with colleagues at Mass General and the clinical trial center there on ROMICAT II, a large randomized trial involving people who came to the ER with acute chest pain. In this trial, we are looking at patients with acute presentations and using cardiac CT to better understand their diagnosis as well as prognosis. I also work with another large trial, PROMISE—again using cardiac CT—involving people with stable chest pain who present in an outpatient setting.

Read more…

New eIRB system launches Aug. 5

IRB go liveThe launch of the new and improved eIRB system is right around the corner! The scheduled go live is set for Wednesday, Aug. 5, 2015. The new eIRB will help us support the rapidly growing research community at OHSU and maintain ahigh standards of compliance as a world class research institution.

Starting Aug. 5, the new eIRB will open for new submissions only. At this time, all current studies will remain in the “old” system. This will allow time for us to ensure a smooth migration of a very large amount of data. Keep your eyes open for announcements on the schedule for full data migration. We will provide as much advance notice as possible for any needed downtime.

Please note that there is currently no scheduled down time for the system to go live on Aug. 5.

Drop-in training sessions will be available in the Lamfrom Biomedical Research Building, room 381, and the Medical Research Building, room 310. Please see the IRB Education site for a schedule of date and times.

Seminar: Model of HIV/AIDS in sub-Saharan Africa, Aug. 3 & 4

If you’re interested in the epidemiological model of HIV/AIDS, this seminar will give you Bershteyn_A_0insight into innovations currently being developed. The seminar will discuss layering detail using individual-based modeling — a strategy to combine HIV biology, behavior, and care-seeking in a unified epidemiological model of HIV/AIDS in sub-Saharan Africa.

This event will be led by Anna Bershteyn, Ph.D., senior research manager and associate principal investigator at the Institute for Disease Modeling based in Bellevue, Wash.

Monday, Aug. 3
11:30 a.m. to 12:15 p.m.
OHSU West Campus, 1st floor seminar room
Hosted by ONPRC/VGTI


Tuesday, Aug. 4
11:30 a.m. to 1 p.m.
School of Nursing, room 122
Hosted by the OHSU-PSU School of Public Health
Lunch will be provided at this event

These seminars are open to the OHSU community. No admission fee or registration is required for either event. For more information, please contact Cara Cooper at


NIMHD seeks input on training in health disparities science

nimhdThe diversity of the U.S. population presents great opportunity but also great challenges. Many populations in America – whether defined by race, ethnicity, immigrant status, disability, sex, gender, or geography – experience higher rates of certain diseases and more deaths and suffering from them compared with the general population. The National Institute on Minority Health and Health Disparities leads scientific research to improve the health of these underserved populations.

To that end, NIMHD is working to develop the next generation of health disparities researchers and is seeking input on how to advance and strengthen predoctoral and postdoctoral interdisciplinary training and mentoring programs in health disparities science.

NIMHD invites comments that include, but are not limited, to:

  • Interdisciplinary training, mentorship, and education on methods relevant to health disparities science, including genetics, epidemiology, population science, systems science, health services research, social and behavioral health sciences, public health, environmental science, and other related biological science disciplines for predoctoral students and postdoctoral fellows
  • Research training and mentoring on the social determinants of health, and population-based interventions to improve health and reduce or eliminate health disparities
  • Training in innovative research methods and statistical analyses for complex, multifactorial research inquiry relevant to health disparities
  • Graduate curriculum development designed to foster interdisciplinary thinking and research synergy
  • Integrated training and mentoring among scientific disciplines across the translational research continuum
  • Best practices for establishing partnerships and collaborations with researchers, clinicians, public health agencies, communities, institutions and other stakeholders to improve understanding of health disparities and to translate research findings into policy and practice
  • Recruitment and retention strategies to encourage participation of graduate students from diverse, underrepresented backgrounds

Responses will be accepted through Aug. 24, 2015, and must be submitted via email to

OCTRI Biomedical Innovation Program funding Q&A session, Aug. 11

Oregon Clinical and Translational Research Institute will be holding an informational Q&A session for the Biomedical Innovation Program Award, which is aimed at investigators who are thinking about submitting a letter of intent (due Sept. 9).

Tuesday, Aug. 11
11 a.m. to 12 p.m.
Mackenzie Hall, room 3198

David Ellison, M.D.,  professor of medicine and associate director of OCTRI, will present.  A light lunch will be provided.

The focus of OCTRI’s Biomedical Innovation Program (BIP) is bench-to-bedside device, diagnostic, and software development. Formed in partnership with Technology Transfer and Business Development (TTBD) in 2012, the BIP has funded a total of 12 projects, led by a diverse group of principal investigators, including clinicians, scientists, and bioengineers. Several of these projects have achieved proof of concept as a result of BIP funding and are being actively marketed by TTBD for licensing agreements with biomedical corporations. Others have formed the basis for start-up companies. The BIP’s objective is to improve human health by moving innovative technologies from academia to the marketplace.

The current RFA can be viewed and download here.

Biomedical Innovation Program highlights

  • Up to $40,000 in grant funding
  • Project management
  • Mentoring from OHSU faculty and staff, regional business partners, BIP review committee members

Questions? Please contact Jonathan Jubera at

For more information about OCTRI awards and the Biomedical Information Program, please visit the OCTRI Funding Opportunities website.


Welcome to the Research News Blog

Welcome to the Research News Blog

OHSU Research News is your portal to information about all things research at Oregon Health & Science University. Visit often for updates on events, discoveries, and important funding information.

Participation Guidelines

Remember: information you share here is public; it isn't medical advice. Need advice or treatment? Contact your healthcare provider directly. Read our Terms of Use and this disclaimer for details.